amoxicillin and tirzepatide Antibiotics: Safe Drug Interactions Mounjaro (Tirzepatide) Injection 12.5 mg/0.5

& Bisschops, R

However, its very hard to get a comprehensive picture, given that there are so many areas that are aging

Some prescribers step the dose down rather than stopping outright, smoothing the return of appetite further, and evidence across the drug class suggests some weight regain is common after stopping, so agreeing in advance what would prompt a return to treatment removes the sting from that possibility

Common reasons for deprescribing include No active indication (e.g., health condition resolved) New or worsening condition Potential risks outweigh anticipated benefits Preventive indication with life-limiting conditions Lack of benefit or ineffectiveness Result of a prescribing cascade Nonadherence Interactions or ADEs Prescribers and pharmacists can use the available prescribing and deprescribing clinical tools, but they must also review all medications and assess the benefit versus risk for individualized patients